Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
Original Article
R.J. Bateman, J. Smith, M.C. Donohue, P. Delmar, R. Abbas, S. Salloway, J. Wojtowicz, K. Blennow, T. Bittner, S.E. Black, G. Klein, M. Boada, T. Grimmer, A. Tamaoka, R.J. Perry, R.S. Turner, D. Watson, M. Woodward, A. Thanasopoulou, C. Lane, M. Baudler, N.C. Fox, J.L. Cummings, P. Fontoura, and R.S. Doody
N Engl J Med 2023;389:1862-1876
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
11/15/2023
Course expires:
11/16/2025
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, November 16, 2025 - 11:59pm.

Facebook
X
LinkedIn
Forward